Get the Stockscreener App
4.59
2.68%
0.12
After Hours:
4.46
-0.13
-2.83%
BiomX Inc stock is traded at $4.59, with a volume of 45,055.
It is up +2.68% in the last 24 hours and up +14.46% over the past month.
BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$4.47
Open:
$4.38
24h Volume:
45,055
Relative Volume:
0.05
Market Cap:
$7.31M
Revenue:
-
Net Income/Loss:
$-23.14M
P/E Ratio:
-4.5306
EPS:
-1.0131
Net Cash Flow:
$-29.23M
1W Performance:
-12.57%
1M Performance:
+14.46%
6M Performance:
-56.47%
1Y Performance:
-74.04%
1-Day Range:
$4.38
$4.7999
1-Week Range:
$4.05
$5.5596
52-Week Range:
$1.5004
$17.27
BiomX Inc Stock (PHGE) Company Profile
Name
BiomX Inc
Sector
Industry
Phone
972 7 23942377
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
4.59 | 7.12M | 0 | -23.14M | -29.23M | -1.0131 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.05 | 123.82B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.28 | 81.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
816.95 | 52.00B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.36 | 44.14B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
352.23 | 40.83B | 4.98B | 69.60M | 525.67M | 0.5198 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Initiated | Ladenburg Thalmann | Buy |
BiomX Inc Stock (PHGE) Latest News
BiomX: Meeting adjourned for lack of quorum; rescheduled for March 11, 2026 - TradingView
Is Haverty Furniture Companies Inc stock a buy or sell2025 Year in Review & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Bull Bear: Does BiomX Inc outperform in volatile marketsJuly 2025 Closing Moves & Safe Entry Momentum Tips - baoquankhu1.vn
BiomX Inc. SEC 10-K Report - TradingView
Does BiomX Inc. stock have upside surprise potentialJuly 2025 Drop Watch & Risk Managed Investment Signals - mfd.ru
BiomX Inc. Announces Board Changes - marketscreener.com
Is BiomX Inc. trading at a discountJuly 2025 Levels & Weekly Breakout Opportunity Watchlist - mfd.ru
BiomX Inc. deconsolidates Israeli subsidiary after insolvency proceedings By Investing.com - Investing.com India
BiomX Inc. deconsolidates Israeli subsidiary after insolvency proceedings - Investing.com
BiomX Restructures After Insolvency and Executive Terminations - TipRanks
Growth Value: Why is BiomX Inc stock going upQuarterly Portfolio Report & High Return Stock Watch Alerts - baoquankhu1.vn
Market Outlook: Is BiomX Inc trading at a discount2025 Market WrapUp & Safe Entry Trade Reports - baoquankhu1.vn
Biomx Inc. Announces Termination of CEO, CFO and CDO for Its Subsidiary Biomx Ltd., Effective January 25, 2026 - marketscreener.com
BiomX (PHGE) Announces Plan to Offer 5.31 Million Shares of Comm - GuruFocus
Buyout Rumor: Can BiomX Inc grow without dilution2025 Bull vs Bear & High Accuracy Investment Signals - baoquankhu1.vn
Aug Opening: Can PENG expand its profit margins2025 Volume Leaders & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
BiomX Inc. Reports Q3 2025 Financial Results and Program Updates - MSN
Aug Macro: How does SNSE correlate with NasdaqWeekly Investment Recap & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Growth Recap: Can BiomX Inc. grow without dilutionWeekly Trade Review & Risk Controlled Swing Alerts - mfd.ru
What's Driving the Market Sentiment Around BiomX Inc? - Benzinga
Growth Recap: Does BiomX Inc outperform in volatile marketsTake Profit & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Three Stocks Jumped On Big News And Bigger Questions - Finimize
BiomX Issues Statement Regarding Recent Common Stock Trading Activity - The Manila Times
BiomX Says Unaware of Any Undisclosed Developments Amid Unusual Stock Trading - TradingView
BiomX Secures $3M Via Private Placement to Boost Financial Fortunes - StocksToTrade
BiomX’s $3M Private Placement Signals Strategic Shift - timothysykes.com
BiomX stock jumps in premarket after SEC filing flags new 19.99% holder - TechStock²
Why Biomx Shares Are Trading Higher By Over 100%; Here Are 20 Stocks Moving Premarket - Benzinga
BiomX Surges In Pre-Market After Pyu Pyu Capital Discloses 19.99% Stake - Nasdaq
Biomx Inc Shares Surge After 13D Filing Reveals Major Stake - Intellectia AI
Setup Watch: Whats next for BiomX Inc stockWall Street Watch & Weekly Watchlist of Top Performers - baoquankhu1.vn
Short Squeeze: Is BiomX Inc a cyclical or defensive stockPortfolio Value Summary & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Aug Chart Watch: Does BiomX Inc have strong fundamentalsJuly 2025 Gainers & Stock Timing and Entry Methods - baoquankhu1.vn
Patterns Watch: Does BiomX Inc stock have upside surprise potentialGap Up & Weekly Sector Rotation Insights - baoquankhu1.vn
Will BiomX Inc. outperform its industry peers2025 Winners & Losers & Free Expert Verified Stock Movement Alerts - bollywoodhelpline.com
Aug Retail: Will BiomX Inc outperform its industry peersWeekly Investment Summary & Reliable Price Breakout Signals - baoquankhu1.vn
BiomX Completes Private Placement and Board Expansion - The Globe and Mail
BiomX appoints Reuven Yeganeh as director and issues Series Y preferred stock - Investing.com Nigeria
BiomX appoints Reuven Yeganeh as director and issues Series Y preferred stock By Investing.com - Investing.com South Africa
BiomX Inc. Appoints Reuven Yeganeh as Class 1 Director, Effective December 19, 2025 - marketscreener.com
BiomX (NYSE: PHGE) closes placement, issues Series Y preferred shares - Stock Titan
Fund Flows: Can BiomX Inc stock double in the next yearQuarterly Performance Summary & Consistent Profit Trade Alerts - baoquankhu1.vn
How interest rate cuts could boost BiomX Inc. stockWeekly Trading Summary & Community Consensus Trade Alerts - Улправда
Is BiomX Inc. stock oversold or undervaluedCPI Data & Technical Entry and Exit Alerts - Улправда
Is BiomX Inc. stock dividend yield sustainableMarket Weekly Review & High Conviction Buy Zone Alerts - Улправда
Is BiomX Inc. stock resilient to inflationNew Guidance & AI Based Buy and Sell Signals - Улправда
Is BiomX Inc. stock ready for breakoutProtective Put Strategies & Free Dynamic Profit Opportunities - Улправда
BiomX Subsidiary Terminates Maryland Facility Lease Agreement - TipRanks
BiomX announces new preferred stock financing and warrants - MSN
Chart Watch: Will BiomX Inc stock sustain uptrend momentum2025 Key Lessons & Reliable Entry Point Trade Alerts - moha.gov.vn
Growth Report: Is BiomX Inc stock recession proofJuly 2025 EndofMonth & High Win Rate Trade Tips - moha.gov.vn
BiomX Inc Stock (PHGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.52%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):